Provided by Tiger Fintech (Singapore) Pte. Ltd.

COEPTIS THERAPEUTICS HOLDINGS INC

8.15
-0.1500-1.81%
Post-market: 8.150.00000.00%17:57 EDT
Volume:50.87K
Turnover:411.25K
Market Cap:27.42M
PE:-1.60
High:8.50
Open:8.13
Low:7.75
Close:8.30
Loading ...

Why Is Coeptis Therapeutics Stock Falling On Friday?

Benzinga
·
28 Dec 2024

Coeptis Therapeutics to Implement 1-for-20 Reverse Stock Split

MT Newswires Live
·
27 Dec 2024

Coeptis Therapeutics announces 1-for-20 reverse stock split

TIPRANKS
·
27 Dec 2024

Coeptis Therapeutics Announces Reverse Stock Split

THOMSON REUTERS
·
27 Dec 2024

Coeptis Therapeutics Announces Reverse Stock Split

PR Newswire
·
27 Dec 2024

Coeptis Therapeutics Makes Bold Strides in Innovation With the Acquisition of Nexgenai Affiliates Network Platform and Launch of Coeptis Technologies

THOMSON REUTERS
·
26 Dec 2024

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies

PR Newswire
·
26 Dec 2024

Coeptis Therapeutics Holdings Inc: Signs Binding Loi to Acquire Key Assets From a Risk Mitigation Software Co

THOMSON REUTERS
·
12 Dec 2024

Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies

PR Newswire
·
12 Dec 2024

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire AI-Powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

THOMSON REUTERS
·
03 Dec 2024

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

PR Newswire
·
03 Dec 2024

BRIEF-Coeptis Therapeutics Announces Phase 1 Data On DVX201 For Covid-19 Treatment Has Been Accepted For Publication In Molecular Therapy Methods And Clinical Development

Reuters
·
07 Nov 2024

Coeptis Therapeutics Announces Phase 1 Data on Dvx201 for Covid-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

THOMSON REUTERS
·
07 Nov 2024

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

PR Newswire
·
07 Nov 2024

BRIEF-Coeptis Therapeutics Holdings enters $20 mln SEPA with Yorkville

Reuters
·
07 Nov 2024

Coeptis Therapeutics Holdings: Enters $20 Million Sepa With Yorkville - SEC Filing

THOMSON REUTERS
·
07 Nov 2024